Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 49
  • Journal CiteScore: 11.20
  • Journal Impact Factor: 8.24
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

- (2012) Volume 4, Issue 2

Evaluation of Antitumor and Antioxidant activity of Flavonoid fraction of Terminalia Catappa against Ehrlich Ascites Carcinoma in Mice

M. Saroja1*, R. Santhi2, S. Annapoorani3
  1. Ph.D Research Scholar, Department of Biochemistry, Avinashilingam University for Women, Coimbatore-641043, Tamilnadu, India.
  2. Associate Professor, Department of Biotechnology, Dr. G. R. Damodhar College of Science, Coimbatore-641014, Tamilnadu, India
  3. Professor, Department of Biochemistry, Biotechnology and Bioinformatics, Avinashilingam University for Women, Coimbatore-641 043, Tamilnadu, India.
Corresponding Author: M. Saroja E-mail: sarojam2011@gmail.com
Received: 03 March 2012 Accepted: 21 March 2012
Citation: M. Saroja*, R. Santhi, S. Annapoorani,"Evaluation of Antitumor and Antioxidant activity ofFlavonoid fraction of Terminalia Catappa againstEhrlich Ascites Carcinoma in Mice", Int. J. Drug Dev.& Res., April-June 2012, 4(2): 180-187
Copyright: © 2012 IJDDR, M. Saroja et al. Thisis an open access paper distributed under thecopyright agreement with Serials Publication, whichpermits unrestricted use, distribution, andreproduction in any medium, provided the originalwork is properly cited.
Related article at Pubmed, Scholar Google
Visit for more related articles at International Journal of Drug Development and Research

Abstract

activity of flavonoid fraction of Terminalia catappa (TcFf) was evaluated against Ehrlich Ascites Carcinoma (EAC) in mice. After 24 hour tumor inoculation the extract was administered for the period of 15,th30,th45th and 60 days. After administration of the last dose followed by 18 h fasting, mice were sacrificed for observation of antitumor activity for each treatment period. The activity of enzymic antioxidants such as Catalase (CAT), Superoxide dismutase (SOD) and glutathione peroxidase (GPX) and the levels of non enzymic antioxidants such as Vitamin A, Vitamin E and Reduced glutathione (GSH) and lipid peroxide (MDA) in the liver homogenate of control and experimental mice were determined. The activities of enzymic antioxidants and the levels of non enzymic antioxidants were decreased in ELA control mice and MDA level was increased. Administration of TcFf significantly altered the antioxidants level and MDA to normal level. The result suggests that flavonod fraction of Terminala catappa exhibited antitumor effect by modulating lipid peroxidation and augmenting antioxidant defense system in EAC bearing mice.

Key words

Terminalia catappa, ELA, antioxidants, lipid peroxidation

INTRODUCTION

Cancer is the second leading cause of death worldwide next to cardiovascular diseases and can be treated with surgery, radiation, chemotherapy, hormone therapy [1] and biological therapy [2] .Emerging evidence suggests that a number of plants are known to be the source of useful drugs in modern medicine and have been accepted currently as one of the main source of cancer chemoprevent drug discovery and development [3,4] due to their diverse pharmacological properties including cytotoxic and cancer chemopreventive effects [5,6]. Intraperitoneally propagated ELA tumor cells in Swiss albino mice are an important experimental approach to study the biology of human cancer. The methanolic extract of aerial parts of Momordica cymbalaria hook F, crude extract and diethylether fractions of Alangium salvifolium flower and ethanolic extract of Tragia Plukenetii R.Smith were found retard the tumor development and increased the life span of ELA tumor bearing mice [7-9].
Terminalia catappa is (family - combretaceae) also known as badam widely grown in tropical regions of the world as an ornamental tree. It is found in the warmer parts of India. It is also known as Indian Almond, Malabar Almond, and Tropical Almond. The aqueous and cold extracts of leaves of the Terminalia catappa have been reported to be antioxidant, hepatoprotective, and anti-diabetic [10].We have already reported that Terminalia catappa leaf protein has antioxidant activity against ELA implanted Swiss albino mice [11]. In the present study was designed to determine the antioxidant and antitumor activity of flavonoid fraction of Terminalia catappa against ELA implanted Swiss albino mice.

MATERIALS AND METHODS

Plant material

Fresh leaves of Terminalia catappa was collected in area free of pesticides and other contaminants from the area surrounding of Coimbatore,Tamilnadu.The collected leaves were washed thoroughly and blotted dry with filter paper and used for the flavonoid fraction preparation.

Preparation of flavonoid fraction

In the preliminary screening, the direct ethyl acetate extract of Terminalia catappa with powdered magnesium + conc.HCl developed an orange to magenta color indicated the presence of flavonoid showed a characteristic color reaction in Shinoda test. The color is due to the reductive conversion of the flavone into the corresponding anthocyanin pigment [12].Knowing the presence of flavonoid in ethyl acetate extract, the extraction was undertaken with 20 g of powdered plant material and 200ml. of light petroleum ether (b.p. 40°– 60° C) in a Soxhlet apparatus for 18 hours to remove the chlorophyll, non flavonoid components and lipid de waxing[13] The treated material was dried and extracted with ethyl acetate using Soxhlet apparatus.[14]This fraction is referred as TcFf.

Animals

Seven to eight weeks old Swiss albino male mice weighing about 25-30 g were brought from small animals breeding station, Thrissur, Kerala. The animals were acclimatized for 60 days under standard laboratory conditions and fed with standard diet with water ad libitum.

Propagation of ELA cell lines

Ehrlich’s Lymphoma Ascites (ELA) tumor cell lines were procured from Amala Cancer Research Centre, Thrissur, Kerala.The mice were acclimatized for two weeks and cells were propagated by intraperitoneal transplantation of 1x106 cells in 100μl of PBS. After 15 days, the cells were drawn from the intraperitoneal cavity and used for the in vitro cytotoxic studies by trypan blue exclusion method.[15] .In vitro cytotoxic studies were carried out to find out the 50% effective dose (ED 50) of Terminalia catappa flavonoid fraction which was 75μg/100μl determined by trypan blue exclusion method. The fraction which showed minimum ED50 was selected for the in vivo studies. All animal experiments were carried out according to the guidelines prescribed by Animal Welfare Board and with the approval of Animal Ethic Committee (Register no: 623/02/b/CPCSEA).

Grouping of animals and Treatment Schedule

The animals were divided in to seven groups with 6 mice in each for each treatment period.The grouping and treatment of animal as follows.
Group 1 received (i.p) 0.1 ml of PBS every day and served as a vehicle control for the experimental group 6 & 7
Group 2 received (i.p) 0.1 ml of paraffin oil, every day and served as a vehicle control for the standard antioxidant silymarin group
Group 3 received (i.p) 0.1 ml of Dimethyl sulphoxide (DMSO) every day and served as a vehicle control for the experimental groups 5 & 6.
Group 4 received (i.p) 25mg standard antioxidant silymarin in 100 ml of paraffin oil / kg body weight.
Group 5 received (i.p) 75mg (ED50) of TcFf in 100ml of DMSO.
Group 6 received 1x106 ELA tumor cells and 75mg of TcFf (i.p) on the same day and TcFf administration was continued for 60 days (TcFf + ELA)
Group 7 received 1x106 ELA tumor cells (i.p) that served as ELA control
The study was continued for the period of 15 days, 30 days, 45 days and 60 days. At the end of the each treatment the mice were sacrificed after an overnight fasting. The liver was dissected, blotted of blood, washed with PBS at pH 7.2 and homogenate was prepared using PBS and used for the determination of CAT, [16] SOD [17], GPx [18] and the non enzymic antioxidants such as vitamin A [19] vitamin E [20] and GSH [21]. A part of the liver homogenates were prepared using Tris HCl for the assessment of the rate of lipid peroxidation.22

STATISTICAL ANALYSIS

The data presented here are means ± SD of 6 mice in each group. The biochemical estimations using mice for 15 days treatment period alone including ELA were subjected to one-way ANOVA and the results of 15 days to 60 days treatment periods excluding ELA treated group were analysed using two way ANOVA using SigmaStat statistical package to test the level of statistical significance at P<0.05

RESULT AND DISCUSSION

In the human body the free radicals are continuously produced due to the oxygen utilization by the cells of the body. This generates a series of reactive oxygen species (ROS) like super oxide anion (O2 -) and hydroxyl (HO·) radicals and non-free radical species such as H2O2, singled oxygen and nitric oxide (NO).Reactive oxygen species and reactive nitrogen species are associated with many pathological conditions such as atherosclerosis, ischemia, and reperfusion injury of many tissues, central nervous system injury, gastritis and cancer [23,24]. Phytocompounds like flavonoids and phenolic acids, commonly found in plants [25] have been reported to have multiple biological and pharmacological activities including antioxidative ,cytotoxic, anticancer [26-28]antimicrobial, antiviral [29]and anti– inflammatory activities [30,31].
Antioxidants cause protective effect by neutralizing free radicals, which are toxic byproducts of natural cell metabolism. The human body has several mechanisms to counteract oxidative stress by producing antioxidants, which are either naturally produced in situ, or externally supplied through foods and/or supplements. These antioxidants act as free radical scavengers by preventing and repairing damages caused by ROS, and therefore can enhance the immune defense and lower the risk of cancer and degenerative diseases[32].
The liver occupies a vital role in the main functions of the organism. It is particularly susceptible to chemically induced injury due to its extensive metabolic capacity and cellular heterogeneity. Oxidative stress occurs when there is an imbalance between reactive oxygen species (ROS) formation and scavenging by antioxidants. Excess generation of ROS can cause oxidative damage to biomolecules resulting in lipid peroxidation, mutagenesis and carcinogenesis[33]. The ELA tumor bearing mice life span was found to be 15-25days with the average life span of 19 days.

Effect on enzymic antioxidants

Table 1 shows the activities of enzymic antioxidants in the liver of control and experimental animals. SOD is a ubiquitous chain-breaking antioxidant found in all aerobic organisms. It is a metalloprotein widely distributed in all cells and plays an important protective role against oxidative damage induced by reactive oxygen species. SOD converts superoxide ion(O2-) to hydrogen peroxide (H2O2) and the hydrogen peroxide thus formed is degraded by CAT and GPx. CAT is present in all major body organs of animals and humans and is especially concentrated in the liver.[34,35].
In the present study ELA tumor induced mice showed a significant decrease in CAT, SOD and GPx activities on 15 days of treatment period when compared to all the controls and all the treatments. Catalase, SOD and GPX activities were found to be significantly increased in TcFf administration to ELA tumor induced mice on all treatment periods when compared to 15 days treatment period. The decreased activities of enzymic antioxidants in ELA induced liver reduces the protection against free
radicals. These enzymic antioxidants activities were found to be increased in mice treated with silymarin and TcFf in all the treatment periods when compared to their respective controls. TcFf administration showed significant increase in CAT,SOD and GPx activities than that of silymarin administration on 30,45 and 60 days when compared to 15 days treatment period which confirms the antioxidative and antitumorigenic role of TcFf.

Effect on non enzymic antioxidants

The levels of non-enzymic antioxidants such as vitamin A and vitamin E and Reduced glutathione(GSH) in the liver of Swiss albino mice on different treatment periods are shown in the Table 2.
GSH is a tripeptide (L-γ-glutamylcysteinylglycine), an antioxidant and a powerful nucleophile, critical for cellular protection such as detoxification from reactive oxygen species, conjugation and excretion of toxic molecules, and control of the inflammatory cytokine cascade[36] .Depletion of GSH in tissues leads to impairment of the cellular defence against reactive oxygen species, and may result in peroxidative injury. Vitamin A is a fat-soluble vitamin, which is essential for growth maintenance and differentiation of epithelial cells. Vitamin A breaks the chain of lipid per oxidation to cell membrane and prevents the formation of lipid peroxide [37]. Vitamin E is a major lipid phase antioxidant that protects against oxidative lipid damage. It scavenges peroxyl radical intermediates in lipid peroxidation and is responsible for protecting PUFA present in cell membrane.In the present study ELA tumor induced mice showed a significant decrease in Vitamin A and Vitamin E and GSH levels on 15 days of treatment period when compared to all the controls and all the treatments. Vitamin A and Vitamin E and GSH levels were found to be significantly increased in TcFf administration to ELA tumor induced mice on all treatment periods when compared to 15 days treatment period. Vitamin A and Vitamin E and GSH levels were found to be increased in mice treated with silymarin and TcFf in all the treatment periods when compared to their respective controls. TcFf administration showed significant increase in the levels of these non enzymic antioxidants than that of silymarin administration on 30,45 and 60 days when compared to 15 days treatment period which confirms the antioxidative and antitumorigenic role of TcFf.
The effect of TcFf, silymarin and ELA on lipid peroxidation in the liver of Swiss albino mice are given in Table 3.
MDA is a major reactive aldehyde that appears during the peroxidation of biological membrane polyunsaturated fatty acid .[38] Therefore, the hepatic content of MDA is used as an indicator of liver tissue damage involving a series of chain reactions.[39] The mice transplanted with ELA tumor cells showed a significant increase in MDA level when compared to all the controls and experimental groups in 15 days treatment period. Coadministration of TcFf to ELA tumor induced mice showed significant decreased levels of MDA in all the treatment period.The level of MDA in liver was found to be significantly decreased in all the treatment periods by the administration of TcFf when compared to DMSO. The level of MDA in the standard antioxidant silymarin treated mice was found to be significantly decreased when compared to paraffin oil treated mice on all treatment periods. Silymarin administration showed more significant decreased levels of MDA in15, 45 and 60 days treatment periods than that of TcFf administered mice. The significant reduced levels of MDA in mice supplemented with the TcFf individually and in ELA tumor induced mice indicated their antilipid peroxidative role

CONCLUSION

On the whole, it can be concluded that flavonoid fraction of Terminalia catappa restored the hepatic lipid peroxidation and antioxidant enzymes such as SOD, bearing mice to near normal levels. Therefore, CAT and GPx as well as non enzymic antioxidants vitamin A and E and GSH in tumor further studies should be conducted to determine the active compounds that are responsible for the antitumor effects and the mechanisms of action involved in the antitumorigenic effect.

Conflict of Interest

NIL

Source of Support

NONE
 

Tables at a glance

Table icon Table icon Table icon
Table 1 Table 2 Table 3
 
5033

References

  1. Gupta M,MazumderVK,Vamsi MLM,Sivakumar T and Kandar CC.Anti-steroidogenic activity of two Indian medicinal plants in mice. J Ethnopharmcol 2004; 90: 21-25
  2. DashoraN,SoddeV,BhagatJ,Prabhu KS and Lobo R.Antitumor activity of dendrophthoe falcate against Ehrlich Ascites Carcinoma in Swiss albino mice. Pharm Crops 2010 ;2:1-7.
  3. Gonzales GF and Valerio LG,Medicinal plants from Peru: a review of plants as potential agents against cancer. Anticancer Agents Med Chem 2010; 6(5):429–444.
  4. Kathiriya A, Das K, Kumar EP and Matha KB.Evaluation of antitumor and antioxidant activity of Oxalis corniculata Linn. against Ehrlich Ascites Carcinoma on mice.Iran J Cancer Prev 2010; 4:157-165.
  5. Dahiru D, William ET and Nadro MS. Protective effect of Zizyphus mauritiana leaf extract on carbon tetrachloride-induced liver injury. Afr J Biotechnol 2005; 4(10) : 1177-1179.
  6. Radha Ramalingam, Subramaniyam Kavimani and Velayudham Ravichandran. Antitumour activity of methanolic extract of Plumeria alba L. leaves against Dalton Lymphoma Ascites in mice,.Int J Health Res 2008; 1(2): 79-84.
  7. Jeevanantham P,Vincent S,Balasubramaniam A,Jayalakshmi B and Senthil Kumar N. Anti Cancer activity of methanolic extract of aerial parts of Momordica Cymbalaria Hook F.against Ehrlich Ascites Carcinoma in mice. J Pharm Sci & Res 2011; 3(8):1408-14.
  8. Meenakshi Sundaram M, Dorairaj S, Rangarajan P and Pemaiah B. Antitumor and antioxidant potential of Tragia Plukenetii R.Smith on Ehrlich ascites carcinoma in mice. Afri J Biotech 2008 ;7 (20): 3527-3530
  9. Ronok Zahan M, Badrul Alam M, Saiful Islam Gopal C, Nargis S, Salman B, Hosain MA, Jesmin MM and Ekramul Haque M.Anticancer Activity of Alangium salvifolium Flower in Ehrlich Ascites Carcinoma Bearing Mice.Int J Cancer Res 2011; 7: 254-262.
  10. Syed Mansoor A, Vrushabendra Swamy BM, Gopkumar P,Dhanapal,R and Chandrashekara VM. Anti-Diabetic Activity of Terminalia catappa Linn.Leaf Extracts in Alloxan-Induced Diabetic Rats.Iranian J Pharmolcol Ther 2005; 4: 36-39.
  11. Santhi R and Annapoorani S, Antioxidantive role of Terminalia catappa leaf protein against ELA induced mice.Int J Drug Dev& Res 2009 ;1:81-83.
  12. KrishnaswamyNR. Chemistry of natural products, Universities Press.India.1999: 197.
  13. Palanivel Muthu Gounder,Balasubramanian Rajkapoor, Raju Senthil kumar, John Wilking Einstein,Ekambaram Prem Kumar,Mani Rupesh Kumar,Kunchu Kavitha,Mohanraj Pradeep Kumar and Balasundaram Jayakar.Hepatoprotective and Antioxidant Effect of Pisonia aculeata L. against CCl4- Induced Hepatic Damage in Rats. Sci Pharm 2008 ;76: 203–215.
  14. Ansari WH, RahmanW, BarracloughD, Maynard R and Scheinman S. Chem Soc 1976:2:1458
  15. Salomi MJ and Panikkar KR.Cytotoxic action of Nigella sativa seeds. Amala Research Bulletin 1989;11: 60-63. 16) Luck H.Methods in enzymatic analysis.Academic Press, New york, 1974;885.
  16. Misra HP and Fridovich I.The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247(10): 3170 – 3175
  17. Rotruck JT,Pope AL, Ganther HE, Swanson AB, Hafeman DG and Hoekstra WG. Selenium: Biochemical role as a component of glutathione peroxidase. Sci.1973;179(73): 588-590.
  18. Bayfield RF and Cole ER. Colorimetric estimation of vitamin A with Trichloroacetic Acid, In: McCormick DB and Wright LD Eds Mtd Enzymol, Part F. Vitamins and Coenzymes. New York: Academic Press.1980;67: 189-195
  19. Rosenberg HR. Chemistry and Physiology of vitamins, Inter science publishers, Inc., New York.1992;452-453. 21) Moron MS, Depierre JW and Mannervik B.Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. BiochemBiophys. Acta.1979;582(1):67-72.
  20. 22) Bishayee S and Balasubramanian AS.Lipid peroxide formation in rat brain. J Neurochem. 1971;18: 909- 920. 23) Costa R, Magalhães A, Pereira J, Andrade P, Valentão P, Carvalho M. and Silva B. Evaluation of free radical-scavenging and antihemolytic activities of quince (Cydonia oblonga) leaf: A comparative study with green tea (Camellia sinensis),Food and Chem Toxico 2009; 47: 860-865.
  21. 24) Manoharan S, Kolanjiappan K, Suresh.K. and Panjamurthy.K.Lipid peroxidation & antioxidants status in patients with oral squamous cell carcinoma ,Indian J Med Res 2008;122: 529-534.
  22. 25) Pawlowska AM, Oleszek, W. and Braca A.Qualiquantitative analyses of flavonoids of Morus nigra L. and Morus alba L.(Moraceae) fruits. J Agric Food Chem 2008;56: 3377-3380.
  23. 26) Cesquini M,Torsoni MA, Ogo GR. and Booh SHT.Induced oxidative damage in sickle bed blood cells and the role of flavonoids. Biomed and Pharm 2003;57: 124-129.
  24. 27) Conforti F, Ioele G, Statti G, Marrelli M, Ragno G. and Menichini F.Antiproliferative activity against human tumor cell lines and toxicity test on mediterranean dietary plants. Food and Chem. Toxico 2008;46: 3325-3332.
  25. 28) Rajkumar V,Guha G. and Ashok kumar R.Antineoplastic activities of Bergenia ciliate rhizome..J Pharm Res 2011;4(2), 443-445
  26. 29) Dash GK and Murthy PN. Antimicrobial activities of few medicinal plants. Int Res J Pharm 2011;(1): 146-152 30) Middleton EJR, Kandaswami C and Theoharides TC. The effects of plant flavonoids on mammaliancells: Implications for inflammation, heart disease and cancer.Pharma Reviews2000; 52:673-751.
  27. 31) Kumar B, Sandhar HK, Prasher S, Tiwari P, Salhan M. and Sharma P.Review of Phytochemistry and Pharmacology of Flavonoids.Int Pharm Sci 2011;1(1):25-41.
  28. 32) Pham-Huy LA, He H and Pham-Huyc C. Free radicals, antioxidants in disease and health.Int J Biomed Sci 2008; 4(2): 89-96
  29. 33) Khan T. and Sultana S. Antioxidant and hepatoprotective potential of Aegle marmelos Correa against CCl4-induced oxidative stress and early tumor events. Journal of Enzyme Inhibition and Medicinal Chemistry 2009;24 (2): 320-7.
  30. 34) Sheela C.G. and Angusti K.T. Antiperoxide effects of S-allyl cysteine sulphoxide isolated from Allium sativum Linn. and gugulipid in cholesterol diet fed rats. Ind J Exp Biol 1995; 33:337-341.
  31. 35) Reedy AC and Lokes BR Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes,Mol Cell Biochem1992;111:117-124.
  32. 36) Brown L.A. Chronic ethanol ingestion and the risk of acute lung injury: a role for glutathioneavailability? Alcol 2004 ;33:191-197.
  33. 37) Lira LQ and Dimenstein R. Vitamin A and gestational diabetes, Rev Assoc Med Bras 2010; 56(3): 355-359
  34. 38) Vaca CE, Wilhelm J and Harms-Rihsdahl M. Interaction of lipid peroxidation product with DNA, A Rev. Mutat. Res. Rev. Genet. Toxicol 1988; 195:137-149.
  35. 39) Ohkawa H, Ohishi N. and Yagi K. Assay for lipid peroxide in animal tissues by thiobarbituric acidreaction. Anal Biochem 1979;95: 351–358.